Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Gas in Piglets Protects Newborn Brains Like Cooling

Molecular Hydrogen Affords Similar Neuroprotection to Therapeutic Hypothermia in a Porcine Model of Neonatal Hypoxic-Ischemic Encephalopathy

Research hubs: Brain & Nervous System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Molecular Hydrogen Affords Similar Neuroprotection to Therapeutic Hypothermia in a Porcine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Evidence type
Animal study (pig)
Authors
Emma Balog, Gábor Remzső, Valéria Tóth-Szűki, Éva Rózsa, Viktória Kovács, Ferenc Domoki
Journal
Antioxidants
Year
2025
Study Type
Pig
Delivery
Gas
Dose
continuous H2 ventilation at 2.1% for 48 hours post-asphyxia
H₂ concentration
2.1%
Duration
2 days
Outcome
Positive
Peer Reviewed
Yes
Country
Hungary

TL;DR

Inhaled hydrogen protected brain tissue and improved brain function in newborns after oxygen deprivation, with neuroprotective effects comparable to therapeutic hypothermia.

Key Finding

Inhaled hydrogen gas provided similar brain protection to therapeutic cooling in newborn pigs with oxygen deprivation injury, particularly in preventing damage to the thalamus.

Summary

Researchers tested whether inhaled hydrogen gas could protect newborn pig brains from damage caused by lack of oxygen and blood flow (a condition called hypoxic-ischemic encephalopathy). They compared hydrogen gas treatment to therapeutic cooling, the current standard treatment. Both treatments reduced brain injury in a specific brain region called the thalamus, though hydrogen gas delayed seizures while cooling eliminated them. Hydrogen gas also produced different electrical activity patterns in the brain compared to cooling.

Practical Takeaway

This animal study suggests hydrogen gas may have potential as a neonatal brain injury treatment, but it is very early research conducted only in pigs. Therapeutic cooling remains the established clinical standard. Any human application would require extensive additional testing before clinical use could be considered.

Abstract (excerpt)

Neonatal hypoxic-ischemic encephalopathy (HIE) remains a major cause of neonatal mortality and long-term disability, despite therapeutic hypothermia (TH) treatment, underscoring the need for further preclinical research. In the present study, we compared the neuroprotection afforded by TH…

Read the full abstract on PubMed